Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Vaccinations

Vaccinations

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Predictive Stability of Aggregation in Glycoconjugate Vaccines Using Advanced Kinetics Modeling and High-Throughput Screening.

Pharmaceutics·2026

Same author

A General Strategy to Compare Stability Slopes of Biologics Using Short-Term data from Post-Change Batches Versus Long-Term Data from Pre-Change Batches.

Pharmaceutical research·2025

Same author

Artificial intelligence for health security in Africa: Benefits, risks and opportunities.

Epidemics·2025

Same author

Bayesian optimization and machine learning for vaccine formulation development.

PloS one·2025

Same author

New High-Throughput Method for Aluminum Content Determination in Vaccine Formulations.

Vaccines·2025

Same author

Quantitative Comparison and Clustering of Circular Dichroism Spectra Using a Symmetrized Weighted Spectral Difference.

The AAPS journal·2024

Search research articles

Related Experiment Video

Updated: Jun 11, 2025

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

Stability Preparedness: The Not-So-Cold Case for Innovations in Vaccine Stability Modelling and Product Release.

Franz Schnetzinger¹, Didier Clénet², Philippe-Alexandre Gilbert³

¹Manufacturing & Supply Chain, Coalition for Epidemic Preparedness Innovations, Askekroken 11, 0277 Oslo, Norway.

|September 28, 2024

Summary

Developing thermostable vaccines is crucial for rapid global health response. Enhanced stability ensures vaccine efficacy and equitable access, supporting initiatives like the 100 Days Mission.

Keywords:

labelling pandemic preparedness stability modelling thermostability vaccine platform

More Related Videos

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality

Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality

Published on: April 7, 2023

Related Experiment Videos

Last Updated: Jun 11, 2025

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality

Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality

Published on: April 7, 2023

Area of Science:

Vaccinology
Biotechnology
Public Health

Background:

Equitable vaccine access is critical for global health security.
Vaccine stability is essential for safety, efficacy, and regulatory approval.
Current stability assessment timelines conflict with rapid response needs during health crises.

Purpose of the Study:

To emphasize the need for stability preparedness in vaccine development.
To explore innovative strategies for monitoring vaccine stability.
To support the 100 Days Mission goal for rapid vaccine development and distribution.

Main Methods:

Review of current vaccine stability challenges and assessment methodologies.
Exploration of thermostable vaccine formulations and manufacturing platforms.
Investigation of advanced technologies, predictive modeling, and adaptive methodologies for stability monitoring.

Main Results:

Thermostable vaccine formulations can accelerate development and regulatory approval.
Innovative stability monitoring enhances efficiency and effectiveness of assessments.
Simplified supply chains through thermostability reduce costs and improve equitable access.

Conclusions:

Proactive development of thermostable vaccine platforms is key to meeting global health challenges.
Advanced stability monitoring strategies are vital for rapid response scenarios.
Enhanced vaccine thermostability directly contributes to equitable access and reduced program costs.